IBB News 239.59 05/29/2014 05:06:49 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 239.59 $IBB

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.48% Gain
Comtex SmarTrend(R) - Tue May 27, 4:18PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 27, 4:17PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Fund (IBB) : Stop activated ($239.00)
Trading Central - Tue May 27, 10:00AM CDT
The ETF has reached our stop loss which was set at $239.00. Performance: -5.55%. Trading strategy: Stop activated ($239.00).

How Will Biotech Fare the Rest of the Year?
George Budwell, The Motley Fool - Motley Fool - Fri May 23, 5:30PM CDT
Biotech has had a fairly volatile year thus far. Shares of the closely watched iShares Nasdaq Biotech Index , for instance, have swung from double-digit gains to high single-digit losses at one point this year. With the index now roughly flat for...

iShares Nasdaq Biotechnology Index Rises 1.92% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu May 22, 3:44PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $229.00 to a high of $236.28. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $231.96 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.92%
Comtex SmarTrend(R) - Thu May 22, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $229.00 to a high of $236.28. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $231.96 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Fund (IBB) : Short Sell @ $226.44
Trading Central - Thu May 15, 10:33AM CDT
From a technical view, the ETF is shaping a symmetrical triangle calling for the continuation of the previous bearish trend. Regarding technical indicators, the daily MACD is facing a strong resistance area while the daily RSI is reversing down from...

R.I.P. the Momentum Trade, 2012-2014
at The Street - Tue May 13, 1:39PM CDT
The momentum trade is dead. And a new momentum trade has risen to take its place.

iShares Nasdaq Biotechnology Index Fund (IBB) : Close former position at last price ($232.50)
Trading Central - Tue May 13, 9:10AM CDT
On a relative basis against the IVV S&P500, the iShares Nasdaq Biotechnology Index Fund is losing upward momentum since it is reversing down from a bearish trend line; we prefer to close our long position opened on April 22nd. Trading strategy: ...

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.42% Yesterday
Comtex SmarTrend(R) - Mon May 12, 4:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:03PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Growth Correction Over - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon May 12, 2:00PM CDT
Where are you finding GARP now?

Market Bulls Gather for Investors Rotating Portfolios
at The Street - Mon May 12, 12:04PM CDT
Despite all the recent divergences, the market is setting up for a bullish week.

Premier Biomedical Advances Technology via Partnerships
ACCESSWIRE - Fri May 09, 9:28AM CDT
Whitefish, MT / May 9, 2014 / Biotechnology stocks have had a rough quarter, with the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) falling more than 6% since February. Investors have started to re-evaluate the sector's lofty valuations, while higher interest rates in the near future could slow the M&A frenzy. As a result, investors may want to shift their attention to high-growth bargains in the industry.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.82%
Comtex SmarTrend(R) - Thu May 08, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.82%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Thu May 08, 3:49PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - Zacks Investment Research - Mon May 05, 1:49AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day

'Fast Money' Recap: The Problem With Growth Stocks
at The Street - Tue Apr 29, 4:00AM CDT
The trading panel wonders why Facebook is having a good quarter when Google has been selling off.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 8

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 6

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 6

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading

Top 5 Most Recently Viewed Articles

Litecoin Soars Over 3% in 24 Hours: Current Trends and Insights

Updated Category News Views 191

Litecoin Experiences Notable Price Surge Litecoin has shown impressive growth, gaining 3.58% in just one day and reaching a price of $65.12. This increase is part of a larger trend, with the coin enjoying a weekly rise of over 5.0%, moving from $61.93 to its current value. Enthusiasts are still keeping an eye on Litecoin's all-time high, which sits at an impressive...

Continue Reading
Innovative Bathroom Accessory Aims for Hygiene and Safety

Updated Category News Views 229

Introduction to Innovative Hygiene Solutions In our modern world, cleanliness is paramount, especially in personal spaces like bathrooms. Understanding the need for better sanitation practices, an inventor from Mechanicsville, Virginia, has sparked a wave of interest with a novel concept: the TOILET COVERALLS. This unique creation serves as a disposable barrier that not...

Continue Reading
Stellantis Releases Early Financial Insights for 2025 Action Plan

Updated Category News Views 256

Stellantis Reveals Initial Financial Figures for 2025 Stellantis N.V., recognized as a key player in the automotive industry, has unveiled its preliminary financial figures for the opening half of 2025. Currently, the company anticipates global consolidated shipments to reach approximately 1.4 million units, which reflects a 6% decrease compared to the previous year. This...

Continue Reading
Enfinity Global Expands Renewable Energy Footprint With 2 GW

Updated Category News Views 254

Enfinity Global Achieves Major Connectivity Milestone for Renewable Projects Enfinity Global, a renowned leader in the renewable energy sector, recently made headlines by securing connectivity for 2 GW of utility-scale solar PV and wind projects. This exciting development is taking place in several states, marking a significant step toward expanding the company's...

Continue Reading
Volta Finance Limited: An Overview of November 2024 Performance

Updated Category News Views 298

Overview of Volta Finance Limited's Performance in November 2024 Volta Finance Limited (LSE: VTA, Amsterdam: VTA) has released its monthly report indicating a net performance increase of +2.1% for November. This achievement elevates the year-to-date portfolio return to an impressive +20.9%. The robust performance was fueled by favorable economic conditions, particularly...

Continue Reading